Alnylam Pharmaceuticals Overview

Founded In
Organization Type
Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.
Founded in 2002, Alnylam Pharmaceuticals is an established company that loves to hire graduates from Northeastern University, with 23.7% of its employees having attended Northeastern University. Alnylam Pharmaceuticals has established itself as a great place to work in Massachusetts, and it is number 9 on Zippia's list of Best Companies to Work for in Cambridge, MA. The average employee at Alnylam Pharmaceuticals makes $81,014 per year. Pay at Alnylam Pharmaceuticals is significantly lower than some of its highest paying competitors, like Gilead Sciences, Acorda Therapeutics, and Vertex Pharmaceuticals, which pay $99,828, $97,279, and $95,952, respectively.
Based in Cambridge, MA, Alnylam Pharmaceuticals is a key player in the pharmaceutical industry with 1,323 employees and an annual revenue of $844.3M.

The Organization’s Mission

Build a top-tier, global, independent biopharmaceutical company founded on RNAi.

Employee Reviews

Be the first to review!

Do you work at Alnylam Pharmaceuticals?

Help us make this company more transparent

Job Openings
61 Positions
Average Salary
$81,014 yearly

The Culture At Alnylam Pharmaceuticals

Information provided by the company

The Team At Alnylam Pharmaceuticals

Key People

Yvonne L. Greenstreet

Phillip A. Sharp

John K. Clarke

David Bartel

Paul Schimmel

Phillip Zamore

Robert Langer

Thomas Tuschl

Alnylam Pharmaceuticals Rankings

Alnylam Pharmaceuticals is ranked #62 on the Best Pharmaceutical Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Alnylam Pharmaceuticals Salaries

Salary Score
The national average salary for an Alnylam Pharmaceuticals employee in the United States is $81,014 per year. Employees in the top 10 percent can make over $136,000 per year, while employees at the bottom 10 percent earn less than $48,000 per year.
Average Alnylam Pharmaceuticals Salary
$38.95 hourly
Updated March 16, 2023
Average Employee Earnings

Highest Paying Jobs At Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Diversity

Diversity Score
We calculated the diversity score of companies by measuring multiple factors, including the ethnic background, gender identity, and language skills of their workforce.

Alnylam Pharmaceuticals Gender Distribution


Research Summary. Using a database of 30 million profiles, Zippia estimates demographics and statistics for Alnylam Pharmaceuticals. Our estimates are verified against BLS, Census, and current job openings data for accuracy. After extensive research and analysis, Zippia's data science team found that:

  • Alnylam Pharmaceuticals has 1,323 employees.

  • 51% of Alnylam Pharmaceuticals employees are women, while 49% are men.

  • The most common ethnicity at Alnylam Pharmaceuticals is White (59%).

  • 16% of Alnylam Pharmaceuticals employees are Asian.

  • 14% of Alnylam Pharmaceuticals employees are Hispanic or Latino.

  • The average employee at Alnylam Pharmaceuticals makes $81,014 per year.

  • Alnylam Pharmaceuticals employees are most likely to be members of the democratic party.

  • On average, employees at Alnylam Pharmaceuticals stay with the company for 4.2 years.

Biggest Alnylam Pharmaceuticals Locations

RankCityJob CountAvg. Salary
1Cambridge, MA96$86,456

Jobs from companies you might like

Do you Work At Alnylam Pharmaceuticals?

Help us make this company more transparent.

Alnylam Pharmaceuticals Employee Political Affiliation

Alnylam Pharmaceuticals employees are most likely to be members of the Democratic Party. The largest donation made to a political party by an Alnylam Pharmaceuticals employee was by Garvin Warner. Garvin Warner donated $49,519 to the Democratic Party.

Alnylam Pharmaceuticals


Democratic Party

100.0 %
Employee Political Donations
NameJob TitlePartyDonation
Garvin WarnerScientistDemocratic Party$49,519
John MaraganoreChief Executive OfficerDemocratic Party$44,150
Barry GreenePresident & Chief Operating OfficerDemocratic Party$8,500
Joshua FriedmanPhysicianDemocratic Party$3,250
Tiffany PatrickRequirements ManagerDemocratic Party$2,601
Alan EisenbergGovernorDemocratic Party$2,500
Manmeet SoniChief Finance OfficerDemocratic Party$2,500
Rachel MeyersScientistDemocratic Party$2,345
Yvonne GreenstreetChief Operating OfficerDemocratic Party$2,288
Jeffrey PoultonExecutive OfficerDemocratic Party$2,288
Show More

Alnylam Pharmaceuticals Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Alnylam Pharmaceuticals Annual Revenue


How Would You Rate The Company Culture Of Alnylam Pharmaceuticals?

Have you worked at Alnylam Pharmaceuticals? Help other job seekers by rating Alnylam Pharmaceuticals.

Highest Paying Alnylam Pharmaceuticals Competitors

Some of the competitors of Alnylam Pharmaceuticals are Gilead Sciences, Acorda Therapeutics, and Vertex Pharmaceuticals. The wages at Gilead Sciences average higher than the other similar companies, where the median salary is $99,828 per year. Employees at Acorda Therapeutics earn an average of $97,279 per year, and the employees at Vertex Pharmaceuticals earn an average salary of $95,952 per year.

Frequently Asked Questions about Alnylam Pharmaceuticals

When was Alnylam Pharmaceuticals founded?

Alnylam Pharmaceuticals was founded in 2002.

How many Employees does Alnylam Pharmaceuticals have?

Alnylam Pharmaceuticals has 1,323 employees.

How much money does Alnylam Pharmaceuticals make?

Alnylam Pharmaceuticals generates $844.3M in revenue.

What industry is Alnylam Pharmaceuticals in?

Alnylam Pharmaceuticals is in the pharmaceutical industry.

What is Alnylam Pharmaceuticals's mission?

Alnylam Pharmaceuticals's mission statement is "Build a top-tier, global, independent biopharmaceutical company founded on RNAi."

What type of company is Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals is a public company.

Who are Alnylam Pharmaceuticals's competitors?

Alnylam Pharmaceuticals competitors include Merck, Johnson & Johnson, Vertex Pharmaceuticals, Gilead Sciences, Regeneron, Forest Laboratories, Sanofi Genzyme, Sarepta Therapeutics, Acorda Therapeutics, Ironwood Pharmaceuticals, Merrimack Pharmaceuticals, Emisphere Technologies, Momenta Pharmaceuticals, PTC Therapeutics, AVEO Oncology, Lexicon Pharmaceuticals, Absorption Systems.

Who works at Alnylam Pharmaceuticals?

Yvonne L. Greenstreet (CEO)

Phillip A. Sharp (Board Member)

John K. Clarke (Board Member)

Show More

Are You An Executive, HR Leader, Or Brand Manager At Alnylam Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

Zippia gives an in-depth look into the details of Alnylam Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alnylam Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Alnylam Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alnylam Pharmaceuticals. The data presented on this page does not represent the view of Alnylam Pharmaceuticals and its employees or that of Zippia.

Alnylam Pharmaceuticals may also be known as or be related to Alnylam Pharmaceuticals, Alnylam Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc. and Alnylam Pharmaceuticals, Inc.